# FDA Inspection 1241519 - Kristen NooShin Ganjoo, M.D. - June 17, 2024

Source: https://www.keypedia.com/records/fda_inspections/kristen-nooshin-ganjoo-md/f3dfdba8-e0ee-4cfd-870b-91fbd8664d75
Source feed: FDA_Inspections

> FDA Inspection 1241519 for Kristen NooShin Ganjoo, M.D. on June 17, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1241519
- Company Name: Kristen NooShin Ganjoo, M.D.
- Inspection Date: 2024-06-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1135959 - 2021-02-08](https://www.keypedia.com/records/fda_inspections/kristen-nooshin-ganjoo-md/fb125cc1-dc6a-48b5-8095-25d2df503ede)

Company: https://www.keypedia.com/companies/kristen-nooshin-ganjoo-md/b3d084ef-4aec-473e-8f1c-a95e8de6f078

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d